- Report
- October 2022
- 70 Pages
Africa
From €4519EUR$4,750USD£3,870GBP
- Report
- January 2021
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- February 2018
- 77 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- May 2023
- 160 Pages
Global
From €5708EUR$5,999USD£4,887GBP
Humulin is a brand of insulin used to treat endocrine and metabolic disorders. It is a recombinant human insulin, produced by genetically engineered bacteria, and is used to treat diabetes mellitus. It is available in several forms, including short-acting, intermediate-acting, and long-acting. Humulin is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is also used to treat other endocrine and metabolic disorders, such as hyperglycemia, hypoglycemia, and polycystic ovary syndrome.
Humulin is a widely used insulin, and is available in many countries around the world. It is available in both generic and branded forms, and is available in both injectable and oral forms. It is also available in combination with other medications, such as metformin and glipizide.
The Humulin market is highly competitive, with many companies offering their own versions of the drug. Some of the major companies in the market include Eli Lilly, Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more